Search Results for 'Her2-Trastuzumab'

Her2-Trastuzumab published presentations and documents on DocSlides.

Her2 + Breast Cancer Laura
Her2 + Breast Cancer Laura
by ximena
Bidstrup. Mrs B is a 49 . yo. woman who attended ...
Module 9: HER2-Positive and
Module 9: HER2-Positive and
by norah
Triple-Negative Breast Cancer. Jamie Carroll, APRN...
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
by marina-yarberry
Management of HER2 Over-Expressed Breast Cancer i...
Metastatic HER2-Positive Breast Cancer: Treatment Selection
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
Eribulin   Mesylate  +  Trastuzumab
Eribulin Mesylate + Trastuzumab
by easyho
as First-Line Therapy for Locally Recurrent or . M...
Mauricio Lema Medina  – Clínica de Oncología Astorga / Clínica SOMA, Medellín
Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín
by delcy
Trastuzumab-emtansine. : A . very. . nice. . poi...
Module 9:  HER2-Positive and Triple-Negative BC
Module 9: HER2-Positive and Triple-Negative BC
by unita
Percent with Patients. Number of Patients (Median)...
Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use
Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use
by gelbero
Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...
William J.
William J.
by tawny-fly
Gradishar. . MD, FACP. Betsy . Bramsen. Profess...
Breast Cancer in Older Patients
Breast Cancer in Older Patients
by ButterflyKisses
Key Issues. Etienne GC . Brain. , MD . PhD. Instit...
Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer
Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer
by faustina-dinatale
Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...
Metastatic  triple-positive
Metastatic triple-positive
by marcos147
breast. . cancer. . needs. . different. . ther...
Antibody–Drug Conjugates
Antibody–Drug Conjugates
by wang
in Development for . Breast Cancer. Sara A. Hurvit...
Antibody–Drug Conjugates in Development for Non-
Antibody–Drug Conjugates in Development for Non-
by elizabeth
s. mall Cell . Lung Cancer. , Gastric Cancer, and ...
Updates in the Treatment of Breast cancer
Updates in the Treatment of Breast cancer
by alexa-scheidler
Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...
ID DB06366 						 CATEGORY
ID DB06366 CATEGORY
by luanne-stotts
Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...
HER2 and Ki67Assessment of regional lymph nodesPhysical examination
HER2 and Ki67Assessment of regional lymph nodesPhysical examination
by arya
Luminal B-like (HER2-positive):!ER-positive!HER2-p...
Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer
Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer
by danika-pritchard
ASCO-CAP Recommendations For HER2 Testing in Brea...
HER2 TESTING IN BREAST CANCER
HER2 TESTING IN BREAST CANCER
by danika-pritchard
Clinical Practice Guideline Update. American Soci...
HER2 TESTING IN BREAST CANCER
HER2 TESTING IN BREAST CANCER
by danika-pritchard
Clinical Practice Guideline Update. American Soci...
Risk of Heart Failure in Breast Cancer Patients After
Risk of Heart Failure in Breast Cancer Patients After
by sophia2
Anthracycline. and . Trastuzumab. Treatment: A R...
Cost Impact Of Biosimiliars in Oncology
Cost Impact Of Biosimiliars in Oncology
by williams
Mansoor A Khan, BS, MS, BCOP. Senior Clinical Phar...
Budget impact and cost-effectiveness of oncology
Budget impact and cost-effectiveness of oncology
by roxanne
biosimilars. Prof. dr. Steven Simoens. Health econ...
Part B Medical Drugs Requiring StepTherapy
Part B Medical Drugs Requiring StepTherapy
by natalie
Drug subject to Step Therapy BRAND NAME GENERIC NA...
Part B Medical Drugs Requiring Step
Part B Medical Drugs Requiring Step
by udeline
-TherapyDrug subject to Step TherapyTry these Opti...
Fast relapsing
Fast relapsing
by danika-pritchard
patients . i.e. Patient relapses during or within...
GIULIANA  D’AURIA UOC Oncologia ASL Roma 2
GIULIANA D’AURIA UOC Oncologia ASL Roma 2
by hadley
Osp. . Pertini-S.Eugenio-CTO. Therapeutic. . app...
Istituto Toscano Tumori –Livorno, Italy
Istituto Toscano Tumori –Livorno, Italy
by payton
Federico . Cappuzzo. Istituto Toscano Tumori. Ospe...
Dawid Sigorski,  Ph.D  .
Dawid Sigorski, Ph.D .
by morgan
Department. of . oncology. . UWM. Epidemiology. ...
update  in                              metastatic breast c
update in metastatic breast c
by min-jolicoeur
. Dr.Mina. . Tajvidi. Radiation . oncologist. ...
Breast Cancer Highlights From San Antonio
Breast Cancer Highlights From San Antonio
by tatyana-admore
Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...
Managing Breast Cancer in the Genomic Era
Managing Breast Cancer in the Genomic Era
by alida-meadow
Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...
New Therapies for Metastatic Breast Cancer
New Therapies for Metastatic Breast Cancer
by alexa-scheidler
Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...
2020 Year in Review: Breast Cancer
2020 Year in Review: Breast Cancer
by caroline
Lisa A. Carey MD, . ScM. University of North Carol...
Changes in Breast Cancer Reports After Second Opinion
Changes in Breast Cancer Reports After Second Opinion
by unita
Dr. Vicente Marco. Department of Pathology. Hospit...
CA BREAST   D r   S ana
CA BREAST D r S ana
by oconnor
ishtiaq. . FCPS R3 general surgery unit one UKSO...
Denise A. Yardley, MD Sarah Cannon Research Institute
Denise A. Yardley, MD Sarah Cannon Research Institute
by lily
Senior Investigator, . Breast Cancer Research. Ten...
Central Asian Journal of
Central Asian Journal of
by cady
15 Medical and Pharmaceutical Sciences Innovation ...
ORIGINALARTICLEBREASTONCOLOGY
ORIGINALARTICLEBREASTONCOLOGY
by emery
SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...